02.01.2015 Views

Antibiotikaprofylax vid kirurgiska ingrepp - SBU

Antibiotikaprofylax vid kirurgiska ingrepp - SBU

Antibiotikaprofylax vid kirurgiska ingrepp - SBU

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Table 4.2.2 continued<br />

Author<br />

Year<br />

Reference<br />

Country<br />

Study<br />

design<br />

Population<br />

characteristics<br />

Intervention<br />

Method<br />

Number indi<strong>vid</strong>uals<br />

Control<br />

Number<br />

indi<strong>vid</strong>uals<br />

Results<br />

Withdrawal<br />

Drop outs<br />

Study quality<br />

and relevance<br />

Comments<br />

Nelson<br />

2009<br />

[1]<br />

Systematic<br />

review<br />

All trials between 1980<br />

to december 2007 concerning<br />

the efficacy of<br />

antimicrobial prophylaxis<br />

for the prevention of postoperative<br />

wound infection<br />

in patients undergoing<br />

colorectal surgery. 182<br />

relevant trials were found<br />

through Medline, EmBase<br />

and Cochrane<br />

I1: Antibiotics prophylaxis<br />

(n=461)<br />

I2: Single-dose (n=757)<br />

I3: Aerobic cover + anaerobic<br />

cover (n=648)<br />

I4: Aerobic cover + anaerobic<br />

cover (n=1 184 included)<br />

I5: Combined non-absorbable<br />

oral + intravenous<br />

prophylaxis (n=1 176)<br />

I6: Combined non-absorbable<br />

oral + intravenous<br />

prophylaxis (n=143)<br />

I7: Antibiotic choice 28 trials<br />

C1: No antibiotics<br />

(n=352)<br />

C2: Multiple doses<br />

(n=1 784)<br />

C3: No aerobic<br />

cover (n=621)<br />

C4: No anaerobic<br />

cover (n=1 210)<br />

C5: Intravenous<br />

prophylaxis alone<br />

(n=1 186)<br />

C6: Oral nonabsorbable<br />

prophylaxis<br />

alone (n=140)<br />

C7: Gold standard<br />

(cefotetan,<br />

cefoxitin, doxycycline,<br />

oral<br />

neomycin/<br />

erythromycinbase).<br />

28 trials<br />

Surgical wound infection<br />

1. Favour antibiotic prophylaxis<br />

vs no antibiotics<br />

RR=0.30 (95% CI 0.22–0.41).<br />

2. Single dose vs multiple<br />

doses RR=1.06 (95% CI<br />

0.88–1.27)<br />

3. Favour additional aerobic<br />

cover RR=0.41 (95% CI<br />

0.23–0.71)<br />

4. Favour additional<br />

anaerobic cover RR=0.55<br />

(95% CI 0.35–0.85)<br />

5. Favour combined nonabsorbable<br />

oral and iv<br />

therapy vs iv therapy<br />

RR=0.55 (95% CI<br />

0.41–0.74)<br />

6. Favour combined<br />

non-absorbable oral and iv<br />

therapy vs non-absorbable<br />

oral therapy RR=0.34<br />

(95% CI 0.134–0.87)<br />

7. Different antibiotic<br />

vs gold standard<br />

RR=0 (95% CI 0.0–0.0)<br />

High<br />

Cochrane analysis<br />

with high quality.<br />

The quality of<br />

studies improved<br />

over the years.<br />

Studies in all<br />

language were<br />

considered<br />

(161 in english)<br />

The table continues on the next page<br />

172 antibiotikaprofylax <strong>vid</strong> <strong>kirurgiska</strong> <strong>ingrepp</strong> KAPITEL 4 • den systematiska litteraturöversikten<br />

173

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!